Georgia's Online Cancer Information Center

Mary Alice Moses: “[I wanted to] increase the number of women who participated in clinical trials.” MaryAlice Moses

Mary Alice Moses

“[I wanted to] increase the number of women who participated in clinical trials.”

When Austell, Ga resident MaryAlice Moses was notified of an opportunity to participate in two cancer prevention clinical trials, she knew it was the right thing to do.

Even though MaryAlice did not have cancer, she wanted a chance to contribute to cancer research. She was aware that the clinical trials presented to her would be used to identify risk factors for developing breast and ovarian cancers.

So, MaryAlice decided to enroll in both "The Sister Study: A Study of the Environmental and Genetic Risk Factors for Breast Cancer" and in the "North Carolina Ovarian Cancer Study." These studies involve individuals who have cancer as well as those who have never had cancer – all to help determine the factors that put a person at higher risk for developing a certain type of cancer.

MaryAlice admits, she was at first skeptical about the intent of clinical trials.

So she conducted some research of her own to learn about the meaning and purposes of clinical trials. Once she learned about their significance in the cancer community, her attitude changed.

MaryAlice states that she got involved with clinical trials in order to "assist in the findings regarding data on African American women and to increase the number of women who participate in clinical trials."

Back to Survivors' Voices


Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.


DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.


Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.